LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Undiagnosed Thyroid Problems Discovered Through Computerized Screening

By LabMedica International staff writers
Posted on 07 Aug 2012
Print article
Scientists in India have developed an improved expert system for the diagnosis of thyroid disease.

Jaganathan Palanichamy and Rajkumar Nallamuthu of the PSNA College of Engineering and Technology (Tamilnadu, India found that the classification of a raw dataset from patient records could allow undiagnosed thyroid problems to be discovered through computerized screening.

The screening algorithm developed by the PSNA team boosts the accuracy of earlier approaches, bringing the level to almost 93.5%, as opposed to earlier tests that had 92% confidence or less. That means that 15 more patients are given neither a false positive nor a false negative of every 1,000 in the screened database.

Over a healthcare network with millions of patients that can amount to significant numbers of people correctly identified with a thyroid problem based on patient records rather than having to carry out specific thyroid function blood tests. The screening approach could also be used by doctors in a clinical setting to assess patients that present with a range of symptoms and so identify with precision whether a thyroid test and subsequent pharmaceutical intervention is required.

Thyroid disease in which either too much thyroid hormone is produced or too little is made are common health problems. An overactive thyroid can lead to increased perspiration, a raised pulse, tremors, anxiety, nervousness and irritability, insomnia, thinning of the skin, fine brittle hair, and muscular weakness. A sluggish thyroid might cause constipation, cold intolerance, decreased sweating, a slow pulse, depression, dry skin, and poor female fertility. Thyroid disease is often asymptomatic and is frequently undiagnosed.

Related Links:

PSNA College of Engineering and Technology



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more